Cardiofaciocutaneous syndrome

Cardiofaciocutaneous syndrome
OMIM	115150
DiseasesDB	30111

WikiDoc Resources for Cardiofaciocutaneous syndrome
Articles
Most recent articles on Cardiofaciocutaneous syndrome Most cited articles on Cardiofaciocutaneous syndrome Review articles on Cardiofaciocutaneous syndrome Articles on Cardiofaciocutaneous syndrome in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Cardiofaciocutaneous syndrome Images of Cardiofaciocutaneous syndrome Photos of Cardiofaciocutaneous syndrome Podcasts & MP3s on Cardiofaciocutaneous syndrome Videos on Cardiofaciocutaneous syndrome
Evidence Based Medicine
Cochrane Collaboration on Cardiofaciocutaneous syndrome Bandolier on Cardiofaciocutaneous syndrome TRIP on Cardiofaciocutaneous syndrome
Clinical Trials
Ongoing Trials on Cardiofaciocutaneous syndrome at Clinical Trials.gov Trial results on Cardiofaciocutaneous syndrome Clinical Trials on Cardiofaciocutaneous syndrome at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Cardiofaciocutaneous syndrome NICE Guidance on Cardiofaciocutaneous syndrome NHS PRODIGY Guidance FDA on Cardiofaciocutaneous syndrome CDC on Cardiofaciocutaneous syndrome
Books
Books on Cardiofaciocutaneous syndrome
News
Cardiofaciocutaneous syndrome in the news Be alerted to news on Cardiofaciocutaneous syndrome News trends on Cardiofaciocutaneous syndrome
Commentary
Blogs on Cardiofaciocutaneous syndrome
Definitions
Definitions of Cardiofaciocutaneous syndrome
Patient Resources / Community
Patient resources on Cardiofaciocutaneous syndrome Discussion groups on Cardiofaciocutaneous syndrome Patient Handouts on Cardiofaciocutaneous syndrome Directions to Hospitals Treating Cardiofaciocutaneous syndrome Risk calculators and risk factors for Cardiofaciocutaneous syndrome
Healthcare Provider Resources
Symptoms of Cardiofaciocutaneous syndrome Causes & Risk Factors for Cardiofaciocutaneous syndrome Diagnostic studies for Cardiofaciocutaneous syndrome Treatment of Cardiofaciocutaneous syndrome
Continuing Medical Education (CME)
CME Programs on Cardiofaciocutaneous syndrome
International
Cardiofaciocutaneous syndrome en Espanol Cardiofaciocutaneous syndrome en Francais
Business
Cardiofaciocutaneous syndrome in the Marketplace Patents on Cardiofaciocutaneous syndrome
Experimental / Informatics
List of terms related to Cardiofaciocutaneous syndrome

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Cardiofaciocutaneous Syndrome (CFC) is an extremely rare and serious genetic disorder.

It is characterized by the following:

• Distinctive facial appearance
• Unusually sparse, brittle, curly scalp hair
• A range of skin abnormalities from dermatitis to thick, scaly skin over the entire body (generalized ichthyosis)
• Heart malformations (congenital or appearing later) especially an obstruction of the normal flow of blood from the lower right ventricle of the heart to the lungs (valvar pulmonary stenosis)
• Delayed growth
• Mental retardation
• Psychomotor retardation
• Foot abnormalities (extra toe or fusion of two or more toes)

Malformations of face and head

Individuals with the disorder usually have distinctive malformations of the craniofacial area including an unusually large head (macrocephaly), prominent forehead, and abnormal narrowing of both sides of the forehead (bitemporal constriction); The nose can be upturned and short with a low nasal bridge; and large ears that are abnormally rotated toward the back of the head. In many cases, affected individuals also have downward slanting eyelid folds, widely spaced eyes, drooping of the upper eyelids, inward deviation of the eyes, and other eye abnormalities including absent eyebrows and eye lashes.

Genetic Causes of CFC

Costello and Noonan syndrome are similar to CFC and their phenotypic overlap may be due to the biochemical relationship of the genes mutated in each syndrome to each other. Genes that are mutated in all three of these syndromes encode proteins that function in the MAP kinase pathway. Mutations that cause CFC are found in the KRAS, BRAF, MEK1 and MEK2 genes. Costello syndrome is caused by mutations in HRas. Mutations that cause Noonan Syndrome have been found in PTPN11 and SOS1. The relative severity of CFC when compared to Noonan Syndrome may reflect the position in the biochemical pathway each gene occupies. Shp2, the protein product of the PTPN11, appears to regulate the MAP kinase pathway at or above the level of SOS1. SOS1 in turn regulates the activities of RAS, RAF, MEK, ERK and p90RSK. SOS1 has been demonstrated to be a target of negative feedback by ERK and p90RSK. Thus, any activating mutation downstream of SOS1 may be subject to less regulation that may mitigate the consequence of such mutations giving rise to the phenotypic differences seen between these syndromes.

External links

• CFC International - Support group for CFC families
• CFC Syndrome at WebMD

Template:WS